Plexium Email Format
Biotechnology ResearchCalifornia, United States11-50 Employees
Plexium is a biotechnology research company based in San Diego, California, focused on targeted protein degradation (TPD). It develops small-molecule therapeutics, including monovalent direct degraders and molecular glues, aimed at first-in-class and best-in-class treatments for high unmet medical needs. Its DELTA Discovery platform, featuring proprietary ultra-high throughput cell-based screening, underpins its pipeline and supports the advancement of clinical-stage protein degraders while expanding the druggable target space for TPD and related areas. The company has 11-50 employees and is located at 9330 Scranton Road 500 San Diego, California 92121 United States, with a website at plexium.com. Reported revenue ranges from $25 million to $50 million and it has approximately $60 million in funding.